Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype
- PMID: 2849512
- DOI: 10.1016/0092-8674(88)90242-5
Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype
Abstract
The v-fms oncogene is capable of producing tumors in vivo and transforming cells in culture; in contrast, the c-fms proto-oncogene is nontransforming. In this report we present the complete nucleotide sequence of a feline c-fms cDNA, the progenitor of the v-fms oncogene. Comparison of this sequence with that of v-fms shows that the proteins encoded by these two genes differ by nine amino acid substitutions and the replacement of 50 C-terminal amino acids present in c-fms by 11 unrelated residues in v-fms. Using chimeric fms genes and site-directed mutagenesis, we have determined that the C-terminal modification present in v-fms is sufficient to generate a partially transforming phenotype, but that mutations at amino acid positions 301 and 374 are required (in addition to the C-terminal modification) to generate a fully transforming fms gene.
Similar articles
-
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.Nature. 1986 Mar 20-26;320(6059):277-80. doi: 10.1038/320277a0. Nature. 1986. PMID: 2421165
-
The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.J Virol. 1986 Aug;59(2):224-33. doi: 10.1128/JVI.59.2.224-233.1986. J Virol. 1986. PMID: 3525854 Free PMC article.
-
Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.Proc Natl Acad Sci U S A. 1988 Aug;85(16):5903-7. doi: 10.1073/pnas.85.16.5903. Proc Natl Acad Sci U S A. 1988. PMID: 2842754 Free PMC article.
-
Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.Behring Inst Mitt. 1991 Jul;(89):93-9. Behring Inst Mitt. 1991. PMID: 1834054 Review.
-
Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF-1 receptor).J Cell Physiol Suppl. 1987;Suppl 5:83-7. doi: 10.1002/jcp.1041330416. J Cell Physiol Suppl. 1987. PMID: 2824535 Review.
Cited by
-
Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells.Mol Cell Biol. 1990 Jun;10(6):2528-38. doi: 10.1128/mcb.10.6.2528-2538.1990. Mol Cell Biol. 1990. PMID: 2140428 Free PMC article.
-
Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.J Virol. 1992 Aug;66(8):4909-18. doi: 10.1128/JVI.66.8.4909-4918.1992. J Virol. 1992. PMID: 1321277 Free PMC article.
-
Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain.EMBO J. 1992 Feb;11(2):551-7. doi: 10.1002/j.1460-2075.1992.tb05086.x. EMBO J. 1992. PMID: 1531631 Free PMC article.
-
Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization.Mol Cell Biol. 1994 Jul;14(7):4843-54. doi: 10.1128/mcb.14.7.4843-4854.1994. Mol Cell Biol. 1994. PMID: 8007983 Free PMC article.
-
Identification of tyrosine 706 in the kinase insert as the major colony-stimulating factor 1 (CSF-1)-stimulated autophosphorylation site in the CSF-1 receptor in a murine macrophage cell line.Mol Cell Biol. 1990 Jun;10(6):2991-3002. doi: 10.1128/mcb.10.6.2991-3002.1990. Mol Cell Biol. 1990. PMID: 2160591 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous